Review Article
MicroRNA Implications across Neurodevelopment and Neuropathology
Table 2
miRNAs involved in neurological diseases.
| microRNA | Neurological disease | Effect | Reference number |
| miR-29a/b-1 | Alzheimer’s disease | downregulation | [79] | miR-128a | Alzheimer’s disease | upregulation | [80] | miR-298 | Alzheimer’s disease | downregulation | [81] | miR-328 | Alzheimer’s disease | downregulation | [81] | miR-146a | Alzheimer’s disease | upregulation | [82] | miR-133b | Parkinson’s disease | downregulation | [83] | miR-19 | Spinocerebellar ataxia type 1 | downregulation | [84] | miR-101 | Spinocerebellar ataxia type 1 | downregulation | [84] | miR-130 | Spinocerebellar ataxia type 1 | downregulation | [84] | miR-9 | Hungtington’s disease | downregulation | [85, 86] | miR-1 | Tourette syndrome | deregulation | [87] | miR-206 | Tourette syndrome | deregulation | [87] | miR-21 | Glioblastoma | upregulation | [88] | miR-124 | Glioblastoma | downregulation | [89] | miR-137 | Glioblastoma | downregulation | [89] | miR-124a | Medulloblastoma | downregulation | [90] | miR-34a | Neuroblastoma | downregulation | [91] | miR-184 | Neuroblastoma | downregulation | [92] | miR-15a | Pituitary adenoma | downregulation | [93–95] | miR-16 | Pituitary adenoma | downregulation | [93–95] | miR-221 | Glioblastoma | upregulation | [88, 96–98] | miR-128 | Glioblastoma | upregulation | [88, 96–98] | miR-181a | Glioblastoma | upregulation | [88, 96–98] | miR-181b | Glioblastoma | upregulation | [88, 96–98] | miR-181c | Glioblastoma | downregulation | [88, 96–98] | miR-9 | Medulloblastoma | downregulation | [99] | miR-125a | Medulloblastoma | downregulation | [99] |
|
|